REQUEST A DEMO
Total
USD $0.00
Search more companies

PrePharma Research Kft. (Hungary)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: PrePharma Research Tanacsado Szolgaltato es Kereskedelmi Kft. Profile Updated: August 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

PrePharma Research Kft. is a company based in Hungary, with its head office in Budapest. The enterprise operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) industry. It was incorporated on April 19, 2005. In its most recent financial highlights, the company reported a net sales revenue increase of 413.73% in 2023. A growth of 72.59% was recorded in its total assets. The net profit margin of PrePharma Research Kft. decreased by 57.3% in 2023.

Headquarters
Zrinyi utca 2. A. ep.
Budapest; Budapest; Postal Code: 1214

Contact Details: Purchase the PrePharma Research Kft. report to view the information.

Basic Information
Outstanding Shares:
Purchase the PrePharma Research Kft. report to view the information.
Incorporation Date:
April 19, 2005
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Elso Betegreferalo Ugynokseg Kft.
Company Performance
Financial values in the chart are available after PrePharma Research Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
413.73%
Total operating revenue
365.32%
Operating profit (EBIT)
36.32%
EBITDA
38.67%
Net Profit (Loss) for the Period
39.66%
Total assets
72.59%
Total equity
25.54%
Operating Profit Margin (ROS)
-60.99%
Net Profit Margin
-57.3%
Return on Equity (ROE)
9.17%
Quick Ratio
-3.6%
Cash Ratio
-4.27%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?